By Brian Bamberger, Practice Lead, Life Sciences Biologics and biosimilars are starting to burst into the American market. Biosimilars are expected to quickly become mainstream in the near future because …
By Michael Burger, Senior Consultant The federal government continues to keep its foot on the gas to further the adoption and effectiveness of electronic prescribing (ePrescribing) through the rulemaking process. …
By Tony Schueth Biosimilars now are being introduced in the United States and are expected to rapidly become lower-cost, mainstream treatments for a range of chronic diseases, including cancer, rheumatoid …
By Tony Schueth New York’s I-STOP (Internet System for Tracking Over-Prescribing Act) went into effect on March 27. The law requires that New York physicians use electronic prescribing (ePrescribing) for …
By Tony Schueth As the Point-of-Care Partners (POCP) team travels the country for conferences and client engagements, we often get asked about New York’s I-STOP (Internet System for Tracking Over-Prescribing …
By Michael Burger, Senior Consultant A study was published recently in the JAMA (link here) titled, “Analysis of Prescribers’ Notes in Electronic Prescriptions in Ambulatory Practice.” The study found a …
By Connie Sinclair, Director, Regulatory Resource Center Massachusetts recently enacted comprehensive legislation to help combat opioid abuse deaths, which have reached crisis proportions in the Bay State and around the …
By Michael Burger, Senior Consultant When passed in 2013, NY’s I-STOP legislation was touted as a bellwether for patient safety, EHR adoption and interoperability. The law requires prescribers, effective August, …
By Poojah Babbrah, Practice Lead, PBM Services Providers, pharmacies and technology vendors in the state of New York are breathing a collective sigh of relief. This afternoon, Governor Cuomo signed …
By Tony Schueth, CEO & Managing Partner ePrescribing has become an integral component of healthcare delivery and the preferred method of prescribing non-controlled medications. Last year, 58% of eligible non-controlled prescription …